Eric Trachtenberg, SEE REMARKS at Kala Pharmaceuticals, Inc. (KALA), sold 2,613 shares at $0.37 ($967) on 2022-06-27, disclosed to the SEC on 2022-06-29.
Scheduled sale ($967) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KALA | SELL | 2022-10-28 | $1K | — | Filing → |
| KALA | SELL | 2022-01-05 | $4K | — | Filing → |
| KALA | SELL | 2021-10-28 | $17K | — | Filing → |